The plant-based food producer boosted its valuation to $4bn and has now raised a total of $1.5bn from investors including GV.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
JD Logistics gets on Kuayue Express
The JD.com subsidiary is set to pay $432m for a majority stake in the GLP-backed logistics services provider through a mixture of primary and secondary investment.
Kin Insurance clinches $35m series B
CSAA subsidiary Avanta Ventures returned for a round that will help the home insurance provider expand across the United States.
Salesforce chimes in as Gong raises $200m
Salesforce Ventures has participated in a series D round for Gong that increased the customer service software provider’s valuation to $2.2bn.
Blend cements $75m series F
Canapi Ventures led a $75m series F round for Salesforce Ventures-backed Blend, valuing the digital lending platform at almost $1.7bn.
Waterdrop makes $200m splash
Tencent and Meituan Dianping-backed healthcare crowdfunding platform Waterdrop has reportedly added $200m to its coffers and pushed its valuation to $2bn.
Trumid trucks in $200m
SGX, Deutsche Börse and Creditease-backed electronic trading platform Trumid has achieved unicorn status following a $200m funding round led by Dragoneer.
Skillshare completes $66m funding project
Hubert Burda was among the returning investors in round that boosted the online learning service’s overall funding to $108m.
Fractyl racks up $55m in series E
YJ Capital and existing investor GV were among the partcipants in the latest round for metabolic disease treatment developer Fractyl.
Brite brings in series D funding
Xiaomi has backed a $50.2m round that lifted the total raised by the SMIC-backed chipmaker to more than $80m in just over a decade.
PPRO picks Citi for $50m round
Citi Ventures has returned to help invest $50m in the online payment platform, two years after participating in a deal the same size that was led by PayPal.
Freeline reaches public markets in $159m IPO
Gene therapy developer Freeline Therapeutics priced an upsized offering at the top of its range following $275m in funding from investors including Novo.
Sight Diagnostics draws $71m
Koch Industries and CK Hutchison both participated in a series D round that pushed the medical imaging system developer’s total funding to more than $124m.
Ginger flavours $50m series D
The mental healthcare app developer boosted its overall funding to $120m in a round that included Cigna Ventures and Kaiser Permanente Ventures.